Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure

Overview of attention for article published in Hepatic medicine evidence and research, November 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,350 followers.

Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure https://t.co/EW06MDY8Lm

16 Nov 2018

Reply Repost Favourite

Dove Medical Press

Article Metrics

Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure

Mentioned by

Citations

Readers on